The DOI matches its Crossref record.
Cancer Survival Corrected for Heterogeneity in Patient Withdrawal
Abstract
Survival from cancer over a certain time period is often measured by the 'relative survival rate'. This is the ratio of the observed survival rate in the group of patients to the survival rate expected in a group of people in the general population, who are similar to the patients with respect to all of the possible factors affecting survival at the beginning of the period, except for the disease under study. When patterns of patient withdrawal differ for a number of subgroups of patients with equal relative survival rates, the current method of derivation of the relative survival rate is biased. A method based on the concept of an 'expected life table' is proposed for removal of the bias. Examples based on material from the Finnish Cancer Registry suggest that the practical performance of the proposed method is better than that of other alternatives, even when the relative survival rates in the subgroups are not equal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285
Cervantes, F., Dupriez, B., Pereira, A., Passamonti, F., Reilly, J. T., Morra, E., Vannucchi, A. M., Mesa, R. A., Demory, J.-L., Barosi, G., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170449 · Cited by 1,255
EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
Sant, M., Allemani, C., Santaquilani, M., Knijn, A., Marchesi, F., & Capocaccia, R. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.018 · Cited by 1,021
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
Sant, M., Aareleid, T., Berrino, F., Bielska Lasota, M., Carli, P. M., Faivre, J., Grosclaude, P., Hédelin, G., Matsuda, T., Møller, H., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg754 · Cited by 1,011
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002
Self-citationLong-term patient survival in ANCA-associated vasculitis
Flossmann, O., Berden, A., de Groot, K., Hagen, C., Harper, L., Heijl, C., Höglund, P., Jayne, D., Luqmani, R., Mahr, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137778 · Cited by 939
Rare cancers are not so rare: The rare cancer burden in Europe
Gatta, G., van der Zwan, J. M., Casali, P. G., Siesling, S., Dei Tos, A. P., Kunkler, I., Otter, R., Licitra, L., Mallone, S., Tavilla, A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.08.008 · Cited by 809
Berrino, F., De Angelis, R., Sant, M., Rosso, S., Lasota, M. B., Coebergh, J. W., & Santaquilani, M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70245-0 · Cited by 807
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
Stiller, C. A., Trama, A., Serraino, D., Rossi, S., Navarro, C., Chirlaque, M. D., & Casali, P. G. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.011 · Cited by 683
On Estimation in Relative Survival
Perme, M. P., Stare, J., & Estève, J. (2012) · Biometrics · doi:10.1111/j.1541-0420.2011.01640.x · Cited by 661
Primary central nervous system vasculitis: analysis of 101 patients
Salvarani, C., Brown, R. D., Calamia, K. T., Christianson, T. J. H., Weigand, S. D., Miller, D. V., Giannini, C., Meschia, J. F., Huston, J., & Hunder, G. G. (2007) · Annals of Neurology · doi:10.1002/ana.21226 · Cited by 631
Cancer survival in Africa, Asia, and Central America: a population-based study
Sankaranarayanan, R., Swaminathan, R., Brenner, H., Chen, K., Chia, K. S., Chen, J. G., Law, S. C., Ahn, Y.-O., Xiang, Y. B., Yeole, B. B., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70335-3 · Cited by 616
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
Lim, K.-H., Tefferi, A., Lasho, T. L., Finke, C., Patnaik, M., Butterfield, J. H., McClure, R. F., Li, C.-Y., & Pardanani, A. (2009) · Blood · doi:10.1182/blood-2009-02-205237 · Cited by 588
Brenner, H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11199-8 · Cited by 543
Interpreting trends in cancer patient survival
DICKMAN, P. W., & ADAMI, H. ‐. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01677.x · Cited by 508
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
Coleman, M. P., Gatta, G., Verdecchia, A., Estève, J., Sant, M., Storm, H., Allemani, C., Ciccolallo, L., Santaquilani, M., & Berrino, F. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg756 · Cited by 483
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
Stiller, C. A., Trama, A., Brewster, D. H., Verne, J., Bouchardy, C., Navarro, C., Chirlaque, M. D., Marcos-Gragera, R., Visser, O., Serraino, D., et al. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.09.009 · Cited by 463
Relative survival and the estimation of net survival: Elements for further discussion
Estève, J., Benhamou, E., Croasdale, M., & Raymond, L. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090506 · Cited by 422
The Swedish rectal cancer registry
Påhlman, L., Bohe, M., Cedermark, B., Dahlberg, M., Lindmark, G., Sjödahl, R., Öjerskog, B., Damber, L., & Johansson, R. (2007) · British Journal of Surgery · doi:10.1002/bjs.5679 · Cited by 381
Estimating and Modeling Relative Survival
Dickman, P. W., & Coviello, E. (2015) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1501500112 · Cited by 353
A computer program package for relative survival analysis
Hakulinen, T., & Abeywickrama, K. H. (1985) · Computer Programs in Biomedicine · doi:10.1016/0010-468x(85)90011-x · Cited by 344
Self-citationKristinsson, S. Y., Landgren, O., Dickman, P. W., Derolf, Å. R., & Björkholm, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0100 · Cited by 319
Period analysis for ‘up-to-date’ cancer survival data
Brenner, H., Gefeller, O., & Hakulinen, T. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.10.013 · Cited by 309
Self-citationCancer Survival: An Overview of Measures, Uses, and Interpretation
Mariotto, A. B., Noone, A.-M., Howlader, N., Cho, H., Keel, G. E., Garshell, J., Woloshin, S., & Schwartz, L. M. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu024 · Cited by 295
The advantage of women in cancer survival: An analysis of EUROCARE-4 data
Micheli, A., Ciampichini, R., Oberaigner, W., Ciccolallo, L., de Vries, E., Izarzugaza, I., Zambon, P., Gatta, G., & De Angelis, R. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.008 · Cited by 284
Blood pressure and five year survival in the very old
Mattila, K., Haavisto, M., Rajala, S., & Heikinheimo, R. (1988) · BMJ · doi:10.1136/bmj.296.6626.887 · Cited by 272
Möller, T. R., Garwicz, S., Barlow, L., Winther, J. F., Glattre, E., Olafsdottir, G., Olsen, J. H., Perfekt, R., Ritvanen, A., Sankila, R., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3173 · Cited by 259
Causes of Late Deaths After Pediatric Cardiac Surgery
Nieminen, H. P., Jokinen, E. V., & Sairanen, H. I. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.040 · Cited by 236
Health in China: The one child family policy: the good, the bad, and the ugly
Hesketh, T., & Zhu, W. X. (1997) · BMJ · doi:10.1136/bmj.314.7095.1685 · Cited by 142
Brenner, H., & Spix, C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601295 · Cited by 23
Metadata
- Authors
- Hakulinen, T.
- Venue
- Biometrics
- Publisher
- JSTOR
- Published
- 1982-12
- Volume
- 38
- Issue
- 4
- Pages
- 933
- ISSN
- 0006-341X (ISSN-L)
- OpenAlex
- W2313027250
- Cited by
- 453
- References
- 0
- FWCI
- 0.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.